Overview

Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations.
Phase:
Phase 1
Details
Lead Sponsor:
POZEN
Treatments:
Esomeprazole
Naproxen